ALX-HPP-502
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALX-HPP-502, covering 2015-09-28 to 2015-09-28. Get the full timeline:
Most recent: Clinical Trial Update: Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09